ホーム > 藤巻 基紀/ FUJIMAKI, Motoki

藤巻 基紀

FUJIMAKI, Motoki

医学医療系 , 講師
Institute of Medicine , Assistant Professor

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
  1. 1. Dysautonomia and dysosmia associated with anti-Hu antibodies induced by immune checkpoint inhibitors: a case report Fujimoto, Masataka; Igari, Kota; Fujimaki, Motoki; Saiki, Shinji
      BMC neurology (2026) Semantic Scholar
  2. 2. A regression analytical model of serum levodopa metabolic profile in Parkinson's disease Akiko Chukyo; Osamu Komori; Motoki Fujimaki; Naoko Kaga (+20 著者) Shinji Saiki
      Heliyon 12: e44615 (2026) Semantic Scholar
  3. 3. Hypertrophic olivary degeneration in a patient with lung cancer. Kota Igari; Motoki Fujimaki; Shinji Saiki
      Practical neurology (2025) Semantic Scholar
  4. 4. Autophagy-dependent versus autophagy-independent ferroptosis Ye Zhu; Motoki Fujimaki; David C. Rubinsztein
      Trends in Cell Biology (2025) Semantic Scholar
  5. 5. Antiproliferative activities through accelerating autophagic flux by basidalin and its analogs in human cancer cells. Tomoe Matagawa; Yukiko Sasazawa; Koki Agui; Motoki Fujimaki (+4 著者) Siro Simizu
      Bioorganic & medicinal chemistry letters 104: 129713 (2024) Semantic Scholar
  6. 6. Loss of WIPI4 in neurodegeneration causes autophagy-independent ferroptosis. Ye Zhu; Motoki Fujimaki; Louisa Snape; Ana Lopez (+1 著者) David C Rubinsztein
      Nature cell biology 26: 542 (2024) Semantic Scholar
  7. 7. Subacute Progressive Hearing Loss and Lower Body Parkinsonism in Primary Sjögren's Syndrome. Mai Shimizu; Motoki Fujimaki; Eriko Igami; Yuta Ishiguro (+2 著者) Nobutaka Hattori
      Internal medicine (Tokyo, Japan) 63: 853 (2024) Semantic Scholar
  8. 8. パーキンソン病初期における甲状腺-肝連関による全身性代謝変化 宮本 健吾; 斉木 臣二; 松本 拡高; 鈴木 絢未 (+10 著者) 服部 信孝
      パーキンソン病・運動障害疾患コングレスプログラム・抄録集 17回: 91 (2023)
  9. 9. パーキンソン病初期における甲状腺-肝連関による全身性代謝変化 宮本 健吾; 斉木 臣二; 松本 拡高; 鈴木 絢未 (+10 著者) 服部 信孝
      パーキンソン病・運動障害疾患コングレスプログラム・抄録集 17回: 91 (2023)
  10. 10. Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PD. Kengo Miyamoto; Shinji Saiki; Hirotaka Matsumoto; Ayami Suzuki (+10 著者) Nobutaka Hattori
      Annals of neurology 93: 303 (2023) Semantic Scholar
  11. 11. Reversible Pisa syndrome caused by chronic subdural hematoma in a patient with Parkinson's disease: a case report. Eriko Igami; Motoki Fujimaki; Mai Shimizu; Yuta Ishiguro (+3 著者) Kazuyuki Noda
      BMC neurology 22: 432 (2022) Semantic Scholar
  12. 12. The different autophagy degradation pathways and neurodegeneration. Angeleen Fleming; Mathieu Bourdenx; Motoki Fujimaki; Cansu Karabiyik (+11 著者) David C Rubinsztein
      Neuron 110: 935 (2022) Semantic Scholar
  13. 13. Non-invasive diagnostic tool for Parkinson's disease by sebum RNA profile with machine learning. Yuya Uehara; Shin-Ichi Ueno; Haruka Amano-Takeshige; Shuji Suzuki (+6 著者) Nobutaka Hattori
      Scientific reports 11: 18550 (2021) Semantic Scholar
  14. 14. Parkinson病患者におけるLevodopa代謝変化と各代謝酵素阻害剤の関係 中鏡 暁子; 斉木 臣二; 高 ひかり; 加賀 直子 (+9 著者) 服部 信孝
      パーキンソン病・運動障害疾患コングレスプログラム・抄録集 14回: 102 (2021)
  15. 15. Huntingtin-lowering strategies for Huntington's disease. Roger A Barker; Motoki Fujimaki; Priya Rogers; David C Rubinsztein
      Expert opinion on investigational drugs 29: 1125 (2020) Semantic Scholar
  16. 16. Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. Haruka Takeshige-Amano; Shinji Saiki; Motoki Fujimaki; Shin-Ichi Ueno (+13 著者) Nobutaka Hattori
      Movement disorders : official journal of the Movement Disorder Society 35: 1438 (2020) Semantic Scholar
  17. 17. Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease. Shin-Ichi Ueno; Taku Hatano; Ayami Okuzumi; Shinji Saiki (+12 著者) Nobutaka Hattori
      Annals of clinical and translational neurology 7: 307 (2020) Semantic Scholar
  18. 18. Mendelian neurodegenerative disease genes involved in autophagy. Eleanna Stamatakou; Lidia Wróbel; Sandra Malmgren Hill; Claudia Puri (+8 著者) David Chaim Rubinsztein
      Cell discovery 6: 24 (2020) Semantic Scholar
  19. 19. Neuroprotective effects of memantine via enhancement of autophagy. Kazuoki Hirano; Motoki Fujimaki; Yukiko Sasazawa; Akihiro Yamaguchi (+9 著者) Nobutaka Hattori
      Biochemical and biophysical research communications 518: 161 (2019) Semantic Scholar
  20. 20. A metabolic profile of polyamines in parkinson disease: A promising biomarker. Shinji Saiki; Yukiko Sasazawa; Motoki Fujimaki; Koji Kamagata (+15 著者) Nobutaka Hattori
      Annals of neurology 86: 251 (2019) Semantic Scholar
1 2
  1. 1. 脳神経内科 第100巻 第4号 藤巻, 基紀
    科学評論社 2024年4月
  2. 2. 日本臨床 2023年8月号 特集 パーキンソン病2023 ―基礎・臨床の最新動向― 藤巻, 基紀
    株式会社日本臨床社 2023年8月
  3. 3. パーキンソン病におけるカフェイン代謝変化と診断への意義 藤巻, 基紀
    CMC出版 2018年9月
  1. 1. 神経疾患におけるFcRn阻害薬：全身型重症筋無力症（gMG）および慢性炎症性脱髄性多発神経炎（CIDP）に対するエフガルチギモドの臨床応用と役割
    第54回日本免疫学会学術集会 2025年12月11日 招待有り
  2. 2. Loss of WIPI4 in neurodegeneration causes autophagy-independent ferroptosis FUJIMAKI, Motoki
    第65回日本神経学会学術大会 / AOCN2024 日本神経学会

 183 total views